BioImpacts : BI

RNA Vaccines: Understanding Their Design, How They Are Delivered, and How They Are Used

Updated

Abstract

RNA vaccines are highlighted as flexible tools for rapid-response vaccination and therapy.

  • Nucleoside-modified mRNA vaccines encapsulated in lipid nanoparticles have shown significant success during the COVID-19 pandemic.
  • Molecular design improvements include codon and sequence optimization, as well as chemical modifications.
  • Delivery optimization strategies are being explored, including lipid nanoparticles, virus-like particles, and targeted systems.
  • Clinical examples in oncology demonstrate the potential of personalized neoantigen approaches and combination therapies.
  • Early preclinical studies indicate possibilities for tolerance induction and localized protein replacement.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free